china glp 1 has approved Pfizer's GLP-1 treatment ​Xianweiying for long-term weight management in overweight or ‌obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Asia's GLP‑1 boom: What food

This occurs because appetite returns to pre-treatment levels and the body's metabolic adaptations to weight loss persist, making weight maintenance challenging without continued intervention

Lack of Improvement Over Time Side effects may sometimes stay the same or even worsen as treatment continues

The Bottom Line The excitement around GLP-1 weight loss therapies has highlighted just how powerful this hormone is in regulating appetite, blood sugar, and metabolic health

Participants were enrolled in Medicare Parts A, B, and D for at least 1 year before starting any of the medications examined in this study

These medications can be expensive, and insurance coverage for weight loss varies widely

Some studies have shown a reduction in major adverse cardiovascular events by 18-20%